Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 418

1.

Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.

Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, Mäkivuokko H, Kajander K, Palva A.

BMC Gastroenterol. 2009 Dec 17;9:95. doi: 10.1186/1471-230X-9-95.

2.

Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.

Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, Mättö J, Mäkelä L, Palva A.

World J Gastroenterol. 2009 Dec 21;15(47):5936-45.

3.

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.

Jeffery IB, O'Toole PW, Öhman L, Claesson MJ, Deane J, Quigley EM, Simrén M.

Gut. 2012 Jul;61(7):997-1006. doi: 10.1136/gutjnl-2011-301501. Epub 2011 Dec 16.

PMID:
22180058
4.

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.

Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A.

Gastroenterology. 2007 Jul;133(1):24-33. Epub 2007 Apr 14.

PMID:
17631127
5.

Sequence analysis of percent G+C fraction libraries of human faecal bacterial DNA reveals a high number of Actinobacteria.

Krogius-Kurikka L, Kassinen A, Paulin L, Corander J, Mäkivuokko H, Tuimala J, Palva A.

BMC Microbiol. 2009 Apr 8;9:68. doi: 10.1186/1471-2180-9-68.

6.

The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects.

Rangel I, Sundin J, Fuentes S, Repsilber D, de Vos WM, Brummer RJ.

Aliment Pharmacol Ther. 2015 Nov;42(10):1211-21. doi: 10.1111/apt.13399. Epub 2015 Sep 17.

7.

Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.

Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A.

Am J Gastroenterol. 2005 Feb;100(2):373-82.

PMID:
15667495
8.

Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.

Andrews CN, Griffiths TA, Kaufman J, Vergnolle N, Surette MG, Rioux KP.

Aliment Pharmacol Ther. 2011 Aug;34(3):374-83. doi: 10.1111/j.1365-2036.2011.04732.x. Epub 2011 Jun 14.

9.

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.

Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y.

Neurogastroenterol Motil. 2012 Jun;24(6):521-30, e248. doi: 10.1111/j.1365-2982.2012.01891.x. Epub 2012 Feb 20.

10.

Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.

Chassard C, Dapoigny M, Scott KP, Crouzet L, Del'homme C, Marquet P, Martin JC, Pickering G, Ardid D, Eschalier A, Dubray C, Flint HJ, Bernalier-Donadille A.

Aliment Pharmacol Ther. 2012 Apr;35(7):828-38. doi: 10.1111/j.1365-2036.2012.05007.x. Epub 2012 Feb 8.

11.

Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.

Rajilić-Stojanović M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM.

Gastroenterology. 2011 Nov;141(5):1792-801. doi: 10.1053/j.gastro.2011.07.043. Epub 2011 Aug 5.

PMID:
21820992
12.

Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives.

Salonen A, de Vos WM, Palva A.

Microbiology. 2010 Nov;156(Pt 11):3205-15. doi: 10.1099/mic.0.043257-0. Epub 2010 Aug 12. Review.

PMID:
20705664
13.

Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome.

Rigsbee L, Agans R, Shankar V, Kenche H, Khamis HJ, Michail S, Paliy O.

Am J Gastroenterol. 2012 Nov;107(11):1740-51.

PMID:
22986438
14.

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

Mättö J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M.

FEMS Immunol Med Microbiol. 2005 Feb 1;43(2):213-22.

15.

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.

Duboc H, Rainteau D, Rajca S, Humbert L, Farabos D, Maubert M, Grondin V, Jouet P, Bouhassira D, Seksik P, Sokol H, Coffin B, Sabaté JM.

Neurogastroenterol Motil. 2012 Jun;24(6):513-20, e246-7. doi: 10.1111/j.1365-2982.2012.01893.x. Epub 2012 Feb 22.

PMID:
22356587
16.

Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.

Shukla R, Ghoshal U, Dhole TN, Ghoshal UC.

Dig Dis Sci. 2015 Oct;60(10):2953-62. doi: 10.1007/s10620-015-3607-y. Epub 2015 Mar 18.

PMID:
25784074
17.

Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients.

Nagel R, Traub RJ, Allcock RJ, Kwan MM, Bielefeldt-Ohmann H.

Microbiome. 2016 Aug 31;4(1):47. doi: 10.1186/s40168-016-0191-0.

18.

Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria.

Maukonen J, Satokari R, Mättö J, Söderlund H, Mattila-Sandholm T, Saarela M.

J Med Microbiol. 2006 May;55(Pt 5):625-33.

PMID:
16585652
19.

Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects.

Chung CS, Chang PF, Liao CH, Lee TH, Chen Y, Lee YC, Wu MS, Wang HP, Ni YH.

Scand J Gastroenterol. 2016;51(4):410-9. doi: 10.3109/00365521.2015.1116107. Epub 2015 Nov 23.

PMID:
26595305

Supplemental Content

Support Center